Bain Capital Specialty Finance (BCSF) Earnings Analysis
Bain Capital Specialty Finance (BCSF) next reports earnings on 2026-08-10, consensus EPS 0.42 USD. Last quarter (2026-05-11) it missed with EPS 0.42 USD vs 0.44 USD est (-4.5%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 11.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BCSF next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | 0.42 USD |
| Revenue estimate | 0.06B |
BCSF earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 0.42 USD | 0.44 USD | -4.5% | Miss |
| 2026-02-26 | 0.46 USD | 0.45 USD | +2.2% | Beat |
| 2025-11-10 | 0.45 USD | 0.45 USD | 0% | Beat |
| 2025-05-05 | 0.5 USD | 0.48 USD | +4.2% | Beat |
| 2025-02-27 | 0.52 USD | 0.49 USD | +6.1% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
BCSF valuation and analyst view
| Trailing P/E | 11.00 |
|---|---|
| Trailing EPS | 1.135 USD |
| Price / book | 0.75 |
| Dividend yield | 15.04% |
| Market cap | 0.82B |
| Analyst consensus | Hold (2 buy / 6 hold / 0 sell) |
| Avg price target | 14 USD |
Related research pages
Frequently asked questions
When is Bain Capital Specialty Finance (BCSF)'s next earnings date?
Bain Capital Specialty Finance is next scheduled to report on 2026-08-10, with a consensus EPS estimate of 0.42 USD and revenue estimate of 0.06B.
Did BCSF beat earnings last quarter?
In its 2026-05-11 report, BCSF posted EPS of 0.42 USD versus a 0.44 USD estimate — a miss of 4.5%.
What is BCSF's earnings track record?
Over the last 5 reported quarters with consensus data, BCSF beat estimates 4 times (80%).
What is BCSF's current P/E ratio and EPS?
BCSF trades at a trailing P/E of 11.00 on trailing EPS of 1.134587543382184 USD.
What do analysts rate BCSF?
Analyst consensus is "Hold" across 8 ratings (0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 14 USD.